Karkinos Healthcare

12/03/2026

True wellness begins with listening to the subtle rhythms of our health and recognising that we ourselves are the best advocate for our own gut health. While our bodies constantly evolve, staying mindful of persistent changes is the most effective way to ensure peace of mind.

If you notice shifts that last for more than a few days—such as a persistent change in bowel habits, lingering abdominal discomfort, or unusual fatigue, treat it as an important conversation with your health. These signals are specific markers that enable early detection of colorectal cancer, enabling timely intervention and improved outcomes.

This Colorectal Cancer Awareness Month, take a proactive step. Explore our 5-minute digital risk assessment - https://knowyourrisk.live.karkinos.in/ #/source=krkwebsite to understand your risk profile and receive personalised guidance on screening and next steps.

09/03/2026

Informed choice sits at the heart of women’s health. As we mark International Women’s Day 2026, it is worth reflecting on how access to meaningful health information can shape long-term wellbeing.

Genomic testing offers insight into inherited risks that may not yet present symptoms. Research shows that when individuals receive actionable DNA findings, over 93% take appropriate medical steps within months. Whole Genome Sequencing (WGS) provides comprehensive data that can help reduce uncertainty and guide more personalised screening and prevention strategies.

To understand what typically happens after a DNA test and how individuals translate results into action — read more here: https://geknowmics.karkinos.in/2026/02/20/what-happens-after-a-dna-test-most-people-take-action-study-finds/

08/03/2026

This International Women’s Day, the conversation turns to something essential — empowering women in understanding and prioritising their health.

Across every phase of life, women’s health deserves timely attention and the right tools to make informed choices. From breast cancer screening and HPV testing to vaccination and genetic insights, preventive care is evolving to offer women a complete picture of their health.

At Karkinos Healthcare, we remain committed to making these pathways to prevention and early diagnosis more accessible across communities.
Because when women prioritise their health, the impact extends far beyond one life.

04/03/2026

MPAICON 2026, themed ‘Decoding Genetics for Health: From Helix to Healing,’ marked the 13th Annual Conference of the Molecular Pathology Association of India. Hosted at Tata Medical Center, Kolkata, the conference convened India’s molecular pathology and advanced diagnostics community on a unified national platform.

Organised by Molecular Pathology Association of India, the event reinforced the expanding role of molecular testing and genomics in defining contemporary diagnostic benchmarks.

Karkinos Healthcare established a presence at the conference, engaging distinguished molecular pathologists, laboratory directors, and key stakeholders across the diagnostics ecosystem. The forum enabled meaningful engagement on our integrated molecular oncology capabilities, scalable sequencing and testing infrastructure, and structured reporting frameworks supporting precision diagnostics.

04/03/2026

Human Papillomavirus (HPV) is one of the most common viral infections of the reproductive tract globally, yet its long-term impact is often misunderstood. Certain high-risk strains are linked to cervical cancer — a disease that is largely preventable through vaccination and regular screening, as emphasised by global health authorities.

Because early HPV infection usually shows no symptoms, awareness plays a critical role in prevention. Timely HPV DNA testing and vaccination can significantly reduce long-term risk and contribute to broader efforts toward cervical cancer elimination.

This HPV Awareness Day, choose prevention. For screening, vaccination guidance, or a self-sampling kit, call 82684 82684.

03/03/2026

Research by Dr Vinod Scaria, Dr Sridhar Sivasubbu, Dr Bani Jolly and Dr Rahul C Bhoyar has identified 52 distinct variants within the Indian population linked to drug response. Whole Genome Sequencing (WGS) is the definitive tool to identify these markers, moving us from ‘one-size-fits-all’ prescriptions to truly personalised, genotype-guided oncology.

Read more:
https://pubmed.ncbi.nlm.nih.gov/40667625/

02/03/2026

Wishing you peace, well-being, and a safe Holi from all of us at Karkinos Healthcare.

02/03/2026

While targeted panels are standard, they often leave the diagnostic odyssey incomplete. For the modern onco-surgeon, Whole Genome Sequencing (WGS) offers a hypothesis-free view of the tumour’s architecture. By leveraging NGS to capture both coding and deep intronic variants, WGS provides the ultimate ROI—eliminating iterative testing and identifying rare, actionable targets early.

Karkinos Healthcare is standardising WGS as the first-line intelligence tool to ensure surgical and systemic interventions are precise, personalised, and permanent.

Review the clinical utility: https://geknowmics.karkinos.in/2026/01/28/how-whole-genome-sequencing-can-shorten-the-long-road-to-a-diagnosis/

28/02/2026

On this Rare Disease Day, we stand with millions facing rare conditions that often go undiagnosed or misdiagnosed. Because an accurate diagnosis is the essential first step, we leverage Whole Genome Sequencing (WGS) to uncover the hidden genetic answers that are transforming how we understand these diseases.

At Karkinos Healthcare, we are committed to supporting patients through every step, from advanced genetic testing to personalised treatment guidance.

If you or your loved ones are seeking clarity, we are here to help navigate the journey toward better health. Reach out to us at 82684 82684.

26/02/2026

The transition to Whole Genome Sequencing introduces the complexity of incidental findings. This article examines the clinical and ethical frameworks required to manage secondary genetic data responsibly.

Explore the clinical perspective: https://geknowmics.karkinos.in/2026/01/23/when-dna-tells-you-more-than-you-asked-for-the-curious-case-of-incidental-findings/

25/02/2026

The Government’s decision to introduce a nationwide HPV vaccination program for adolescent girls, signals a structural shift in how India is approaching cervical cancer prevention. Vaccination lays the foundation for population-level protection, and when supported by timely screening and genomic-led surveillance through NGS-based HPV testing and Whole Genome Sequencing (WGS), it enables earlier identification of high-risk HPV strains and clearer clinical decision-making. For families, clinicians, and health systems, this is an opportunity to prioritise timely vaccination and informed screening—bringing prevention and precision together in women’s health.

ETHealthworld ET Pharma

Source: https://health.economictimes.indiatimes.com/news/policy/centre-to-roll-out-free-hpv-vaccination-for-adolescent-girls-across-india-soon-official-sources/128750584?utm_source=Mailer&utm_medium=newsletter&utm_campaign=ethealth_news_2026-02-25&dt=2026-02-25&em=c2hydXRpLmR1dHRhQGthcmtpbm9zLmlu

The Government of India is set to roll out a free nationwide HPV vaccination programme for 14-year-old girls to prevent cervical cancer. Using the Gardasil quadrivalent vaccine, the initiative will be implemented at government health facilities under medical supervision, aligning with WHO guidelines...